Rapid molecular detection of airway pathogens in lung transplant recipients
Jonathan Hoover(Genomic Health (United States)), John R. Greenland(University of California, San Francisco), Steven R. Hays(University of California, San Francisco), Michelle A. Mintz(University of California, San Francisco), Jonathan P. Singer(University of California, San Francisco), Joy Chen(University of California San Diego), Fred Deiter(University of California, San Francisco), Daniel R. Calabrese(San Francisco VA Health Care System), Jasleen Kukreja(University of California, San Francisco), Emily Aminian(University of California, San Francisco)
Cited by 18
Related Papers
Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
|Science Translational Medicine|2021|237
Clinical outcomes and serologic response in solid organ transplant recipients with COVID-19: A case series from the United States
|American Journal of Transplantation|2020|67
Natural killer cells activated through NKG2D mediate lung ischemia-reperfusion injury
|Journal of Clinical Investigation|2020|66
Treatment of immunocompromised COVID‐19 patients with convalescent plasma
|Transplant Infectious Disease|2020|53